These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15082129

  • 21. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
    Kaasinen V, Vilkman H, Hietala J, Någren K, Helenius H, Olsson H, Farde L, Rinne J.
    Neurobiol Aging; 2000; 21(5):683-8. PubMed ID: 11016537
    [Abstract] [Full Text] [Related]

  • 22. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457.
    Okubo Y, Olsson H, Ito H, Lofti M, Suhara T, Halldin C, Farde L.
    Neuroimage; 1999 Dec; 10(6):666-74. PubMed ID: 10600412
    [Abstract] [Full Text] [Related]

  • 23. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
    Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG.
    J Nucl Med; 1995 Jul; 36(7):1275-81. PubMed ID: 7790956
    [Abstract] [Full Text] [Related]

  • 24. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
    Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C.
    Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
    [Abstract] [Full Text] [Related]

  • 25. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC, Montgomery AJ, Grasby PM, Hume SP.
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [Abstract] [Full Text] [Related]

  • 26. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A.
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [Abstract] [Full Text] [Related]

  • 27. Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
    Narendran R, Mason NS, May MA, Chen CM, Kendro S, Ridler K, Rabiner EA, Laruelle M, Mathis CA, Frankle WG.
    Synapse; 2011 Jan; 65(1):35-40. PubMed ID: 20506186
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.
    Biol Psychiatry; 2005 Feb 01; 57(3):229-38. PubMed ID: 15691523
    [Abstract] [Full Text] [Related]

  • 32. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
    Yasuno F, Suhara T, Okubo Y, Ichimiya T, Takano A, Sudo Y, Inoue M.
    Psychiatry Res; 2005 Apr 30; 138(3):197-207. PubMed ID: 15854788
    [Abstract] [Full Text] [Related]

  • 33. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain.
    Pertovaara A, Martikainen IK, Hagelberg N, Mansikka H, Någren K, Hietala J, Scheinin H.
    Eur J Neurosci; 2004 Sep 30; 20(6):1587-92. PubMed ID: 15355325
    [Abstract] [Full Text] [Related]

  • 34. Extrastriatal dopamine D2-receptor availability in social anxiety disorder.
    Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S.
    Eur Neuropsychopharmacol; 2017 May 30; 27(5):462-469. PubMed ID: 28377075
    [Abstract] [Full Text] [Related]

  • 35. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H, Farde L.
    Neuroimage; 2001 Oct 30; 14(4):936-45. PubMed ID: 11554812
    [Abstract] [Full Text] [Related]

  • 36. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
    Aalto S, Ihalainen J, Hirvonen J, Kajander J, Scheinin H, Tanila H, Någren K, Vilkman H, Gustafsson LL, Syvälahti E, Hietala J.
    Psychopharmacology (Berl); 2005 Nov 30; 182(3):375-83. PubMed ID: 16001106
    [Abstract] [Full Text] [Related]

  • 37. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
    Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T, Nakashima Y, Nakayama K, Tanada S, Suzuki K, Halldin C, Farde L.
    Arch Gen Psychiatry; 2002 Jan 30; 59(1):25-30. PubMed ID: 11779278
    [Abstract] [Full Text] [Related]

  • 38. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions.
    Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L.
    Nucl Med Commun; 2001 Nov 30; 22(11):1215-21. PubMed ID: 11606887
    [Abstract] [Full Text] [Related]

  • 39. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.
    Ikoma Y, Ito H, Arakawa R, Okumura M, Seki C, Shidahara M, Takahashi H, Kimura Y, Kanno I, Suhara T.
    Neuroimage; 2008 Oct 01; 42(4):1285-94. PubMed ID: 18585466
    [Abstract] [Full Text] [Related]

  • 40. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI.
    Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L.
    Neuroimage; 2013 May 15; 72():1-9. PubMed ID: 23296186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.